Loading provider…
Loading provider…
Cardiovascular Disease Physician in Los Angeles, CA
NPI: 1346281748Primary Practice Location
RONALD REAGAN UCLA MEDICAL CENTER
757 Westwood Plz, Los Angeles, CA
Primary Employer
UCLA Medical Plaza
uclahealth.org
HQ Phone
Get MD Tamara's Phone Numberphone_androidMobile
Get MD Tamara's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2000 - 2026
CA State Medical License

American Board of Internal Medicine
Cardiovascular Disease

National Board of Echocardiography
Diplomat
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
Medical School
Until 1999
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Cardiovascular Disease
2002 - 2006
Residency • Internal Medicine
1999 - 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 166 | 169 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 131 | 242 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 37 | 37 |
| 4 | 99421Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 30 | 39 |
| 5 | 93018Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician interpretation and report | 24 | 24 |
B-type natriuretic peptide levels in obese patients with advanced heart failure.
Pro-HEART - a randomized clinical trial to test the effectiveness of a high protein diet targeting obese individuals with heart failure: rationale, design and baseline characteristics.
Authors: Michele Hamilton, Dawn Lombardo
Publication Date: 2013-06-23
Lead Sponsor: University of California, Los Angeles
Intervention / Treatment: DEVICE: 30-minute Virtual Reality (VR) Experience delivered through Oculus Quest 2 VR headset
Lead Sponsor: University of California, Los Angeles
Intervention / Treatment: DRUG: Metformin
Lead Sponsor: University of California, Los Angeles
Intervention / Treatment: DEVICE: Body Composition Analysis InBody Scale